NASDAQ:MSON - Misonix Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$12.95 -0.10 (-0.77 %)
(As of 06/19/2018 04:00 PM ET)
Previous Close$13.05
Today's Range$12.75 - $13.35
52-Week Range$7.05 - $13.35
Volume8,253 shs
Average Volume11,413 shs
Market Capitalization$123.20 million
P/E RatioN/A
Dividend YieldN/A
Beta0.13
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells, as well as other medical devices. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wounds, and maxillo-facial applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Receive MSON News and Ratings via Email

Sign-up to receive the latest news and ratings for MSON and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorComputer and Technology
SymbolNASDAQ:MSON
CUSIPN/A
Phone631-694-9555

Debt

Debt-to-Equity RatioN/A
Current Ratio5.48
Quick Ratio4.24

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$27.27 million
Price / Sales4.46
Cash FlowN/A
Price / CashN/A
Book Value$3.12 per share
Price / Book4.15

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-1,680,000.00
Net Margins-17.36%
Return on Equity-1.68%
Return on Assets-1.42%

Miscellaneous

Employees92
Outstanding Shares9,400,000

Misonix (NASDAQ:MSON) Frequently Asked Questions

What is Misonix's stock symbol?

Misonix trades on the NASDAQ under the ticker symbol "MSON."

How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) posted its quarterly earnings data on Monday, May, 7th. The medical equipment provider reported $0.23 earnings per share for the quarter. The medical equipment provider earned $12.44 million during the quarter. Misonix had a negative net margin of 17.36% and a negative return on equity of 1.68%. View Misonix's Earnings History.

Who are some of Misonix's key competitors?

Who are Misonix's key executives?

Misonix's management team includes the folowing people:
  • Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 48)
  • Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 62)
  • Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 51)
  • Mr. Richard A. Zaremba, Special Projects Mang. (Age 63)
  • Mr. Dan Voic, VP of R&D and Engineering (Age 56)

Has Misonix been receiving favorable news coverage?

News articles about MSON stock have been trending somewhat positive recently, Accern reports. Accern scores the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Misonix earned a media sentiment score of 0.03 on Accern's scale. They also assigned press coverage about the medical equipment provider an impact score of 44.92 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are Misonix's major shareholders?

Misonix's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (4.28%). Company insiders that own Misonix stock include Joseph P Dwyer, Michael A Mcmanus Jr, Patrick A Mcbrayer, Stavros G Vizirgianakis and Thomas M Patton. View Institutional Ownership Trends for Misonix.

Which institutional investors are selling Misonix stock?

MSON stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP. View Insider Buying and Selling for Misonix.

How do I buy shares of Misonix?

Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Misonix's stock price today?

One share of MSON stock can currently be purchased for approximately $12.95.

How big of a company is Misonix?

Misonix has a market capitalization of $123.20 million and generates $27.27 million in revenue each year. Misonix employs 92 workers across the globe.

How can I contact Misonix?

Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.


MarketBeat Community Rating for Misonix (MSON)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  49 (Vote Outperform)
Underperform Votes:  54 (Vote Underperform)
Total Votes:  103
MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe MSON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.